Scarica l'app Stockscreener
14.54
1.56%
-0.23
Dopo l'orario di chiusura:
14.74
0.20
+1.38%
Alpha Tau Medical Ltd Borsa (DRTS) Ultime notizie
Clinical Trial Progress Might Change The Case For Investing In Alpha Tau Medical (DRTS) - simplywall.st
Alpha Tau Medical Ltd Balance Sheet – FWB:H44 - TradingView
Debt to assets ratio of Alpha Tau Medical Ltd – FWB:H44 - TradingView
Net income of Alpha Tau Medical Ltd – FWB:H44 - TradingView
Alpha Tau Medical stock trades at USD 15.30 - ad-hoc-news.de
Alpha Tau Medical (DRTS) Reports Early Trial Progress, Is The Premium Already Priced In? - simplywall.st
Alpha Tau Medical Ltd.(NasdaqCM: DRTS) added to S&P Global BMI Index - marketscreener.com
Alpha Tau Medical stock holds steady as investors await next results - ad-hoc-news.de
How Early Cancer Trial Results Will Impact Alpha Tau Medical Stock (DRTS) - simplywall.st
Alpha Tau Medical Ltd stock hits 52-week high at 15.2 USD - Investing.com Australia
Alpha Tau’s Cancer Trials Keep Beating Expectations. Three Major Data Readouts Are Next. By FinanceWire - Investing.com
Alpha Tau's Cancer Trials Keep Beating Expectations. Three Major Data Readouts Are Next. - benzinga.com
DRTS Stock Gets A Pre-Market Boost – Retail Shrug Off Wider Q1 Loss Ahead Of Key Pancreatic Cancer Data Reveal This Week - Stocktwits
Oramed Pharmaceuticals: Hold Reiterated As Alpha Tau Investment Delivers And More (ORMP) - Seeking Alpha
Is Trial Enrollment Completion Altering The Investment Case For Alpha Tau Medical (DRTS)? - simplywall.st
Is IMPACT Pilot Enrollment Completion Reshaping The Investment Case For Alpha Tau Medical (DRTS)? - simplywall.st
Alpha Tau Medical stock hits 52-week high at 15.11 USD By Investing.com - Investing.com Australia
Alpha Tau Medical stock hits 52-week high at 15.11 USD - Investing.com
Alpha Tau: Approaching Massive Year-End; Pounding The Table On Potential GBM Breakthrough - Seeking Alpha
Alpha Tau Medical Ltd. Warrant (DRTSW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Alpha Tau to Participate in September Investor Conferences - Alpha Tau Medical
H.C. Wainwright reiterates Alpha Tau Medical stock rating on trial enrollment By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates Alpha Tau Medical stock rating on trial enrollment - Investing.com Nigeria
Alpha Tau Medical (DRTS) finishes pancreatic IMPACT study signup - Stock Titan
Alpha Tau’s pancreatic cancer study grows from 12 to 48 patients as enrollment closes - Stock Titan
Alpha Tau Completes Patient Enrollment in its Multicenter IMPACT Pancreatic Cancer Pilot Study of Alpha DaRT® Following Strong Demand and Multiple Expansions - Yahoo Finance
Alpha Tau Medical Ltd. Warrant (DRTSW) Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com
Alpha Tau Medical Warrant (DRTSW) Rises 4.1% to $4.05 as Support HoldsStock Picks - careplusvn.com
Alpha Tau Medical (DRTS) officer schedules next stock sale under 10b5-1 plan - Stock Titan
Alpha Tau Medical (NASDAQ:DRTS) Sets New 1-Year HighHere's What Happened - MarketBeat
Alpha Tau Medical stock hits 52-week high at 14.79 USD - Investing.com
Alpha Tau’s Clinical Momentum Put Its Cancer Tech On The Map - Finimize
Price to sales forward of Alpha Tau Medical Ltd. – NASDAQ:DRTSW - TradingView
Price to earnings forward of Alpha Tau Medical Ltd. – NASDAQ:DRTSW - TradingView
Price to earnings forward of Alpha Tau Medical Ltd. – BOATS:DRTSW - TradingView
DRTS Stock Price, Quote & Chart - ChartMill
Is Alpha Tau Medical’s (DRTS) Steepening Loss Curve Reframing Its High-Risk Innovation Strategy? - simplywall.st
Alpha Tau Medical Ltd.: Fundamental Analysis and Financial Ratings | DRTS | IL0011839383 - marketscreener.com
Alpha Tau Medical (XTAE:DRTS) Cyclically Adjusted Price-to-FCF : (As of Aug. 15, 2026) - GuruFocus
Alpha Tau Medical (XTAE:DRTS) Shiller PE Ratio : (As of Aug. 21, 2026) - GuruFocus
DRTS Forecast — Price Target — Prediction for 2027 - TradingView
Q3 EPS Estimate for Alpha Tau Medical Decreased by Analyst - MarketBeat
Alpha Tau Medical Warrant (DRTSW) Surges 8.96% to $3.89 as Traders Target Key ResistanceTrend Continuation Trade - careplusvn.com
Alpha Tau Medical (NASDAQ:DRTS) Stock Price Down 5.4% Following Insider Selling - MarketBeat
Alpha Tau Medical (NASDAQ:DRTS) CFO Sells $248,220.00 in Stock - MarketBeat
H.C. Wainwright raises Alpha Tau Medical stock price target to $16 - Investing.com
Five Takeaways from AHNS 2026: Alpha DaRT in Combination with Immunotherapy for Advanced Head and Neck Cancer - Alpha Tau Medical
3.06%
2.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):